Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
85.6M
-
Number of holders
-
68
-
Total 13F shares, excl. options
-
38.5M
-
Shares change
-
+133K
-
Total reported value, excl. options
-
$174M
-
Value change
-
+$996K
-
Number of buys
-
45
-
Number of sells
-
-14
-
Price
-
$4.53
Significant Holders of Larimar Therapeutics, Inc. - Common Stock (LRMR) as of Q1 2023
74 filings reported holding LRMR - Larimar Therapeutics, Inc. - Common Stock as of Q1 2023.
Larimar Therapeutics, Inc. - Common Stock (LRMR) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.5M shares
of 85.6M outstanding shares and own 44.92% of the company stock.
Largest 10 shareholders include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (16.9M shares), CHI Advisors LLC (2.75M shares), PERCEPTIVE ADVISORS LLC (2.28M shares), Verition Fund Management LLC (1.94M shares), Woodline Partners LP (1.68M shares), Opaleye Management Inc. (1.4M shares), VANGUARD GROUP INC (1.29M shares), JANUS HENDERSON GROUP PLC (1.07M shares), GREAT POINT PARTNERS LLC (900K shares), and MANGROVE PARTNERS (806K shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.